Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharma crawled time : 12:00 save search
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Published: 2024-04-19 (Crawled : 12:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.83%
H: 1.35%
C: 1.2%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 1.07%
H: 1.22%
C: 1.11%
first pharma royalty financial results
Royalty Pharma Declares Second Quarter 2024 Dividend
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: -1.5%
H: 0.84%
C: 0.25%
pharma royalty
Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer’s Disease Therapeutic
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
SILO | $1.97 0.0% 40K
|
Finance and Insurance
|
| O: 1.87%
H: 4.59%
C: -3.67%
pharma disease alzheimer’s acquire spc-14
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 10, 2024
Published: 2024-04-10 (Crawled : 12:00) - biospace.com/
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: -4.11%
H: 0.81%
C: 0.15%
pharma nasdaq grants
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-10 (Crawled : 12:00) - bridgebio.com
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: -4.11%
H: 0.81%
C: 0.15%
pharma nasdaq grants
NewAmsterdam Pharma Enrolls Over 9,000 Patients in Pivotal Phase 3 PREVAIL Global Cardiovascular Outcome Trial Evaluating the Effect of Obicetrapib in Patients with Established Atherosclerotic Cardiovascular Disease
Published: 2024-04-09 (Crawled : 12:00) - globenewswire.com
NAMS | $19.98 2.78% 2.7% 140K
|
n/a
|
| O: -6.3%
H: 2.72%
C: -2.67%
pharma disease global trial cardiovascular
Traws Pharma Announces New Employee Inducement Grants
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
| Email alert
Add to watchlist
pharma grants employee
aTyr Pharma to Participate in April Investor Conferences
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: -1.01%
H: 0.0%
C: -3.05%
pharma
NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
NAMS | $19.98 2.78% 2.7% 140K
|
n/a
|
| O: 6.23%
H: 2.77%
C: -10.21%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.47%
H: 0.23%
C: -0.99%
pharma business
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
PCSA | $1.58 1.28% 1.27% 19K
|
Producer Manufacturing
|
| O: 3.08%
H: 5.13%
C: 1.07%
pharma conference biotech pharmaceuticals
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
COCP | $1.495 -1.39% 7.6K
|
Health Technology
|
| O: 2.68%
H: 13.73%
C: -8.5%
pharma antiviral financial results
NewAmsterdam Pharma to Present New Analysis from the Phase 2 ROSE2 Trial Evaluating Obicetrapib in Combination with Ezetimibe at 2024 American College of Cardiology Congress
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
NAMS | $19.98 2.78% 2.7% 140K
|
n/a
|
| O: -1.03%
H: 2.61%
C: 1.91%
pharma congress trial cardiology
Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042
Published: 2024-03-20 (Crawled : 12:00) - globenewswire.com
LUMO | $2.57 -1.91% -1.95% 12K
|
Health Technology
|
| O: -4.7%
H: 12.62%
C: 12.62%
lum-201 pharma patent granted
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - March 20, 2024
Published: 2024-03-20 (Crawled : 12:00) - biospace.com/
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: 0.46%
H: 1.37%
C: 0.25%
pharma nasdaq grants
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-20 (Crawled : 12:00) - bridgebio.com
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: 0.46%
H: 1.37%
C: 0.25%
pharma nasdaq grants
Nuvectis Pharma Announces Upcoming Presentations at the 2024 American Association for Cancer Research Meeting
Published: 2024-03-19 (Crawled : 12:00) - globenewswire.com
NVCT | $6.85 1.93% 1.9% 44K
|
|
| O: 3.64%
H: 4.62%
C: -19.02%
pharma association cancer research meeting
Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A
Published: 2024-03-19 (Crawled : 12:00) - globenewswire.com
COCP | $1.495 -1.39% 7.6K
|
Health Technology
|
| O: 1.35%
H: 0.0%
C: -5.33%
cc-4234 fda pharma influenza cc-42344
Silo Pharma Files Patent for Groundbreaking Ketamine Implant Therapeutic to Target Fibromyalgia and Chronic Pain
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
SILO | $1.97 0.0% 40K
|
Finance and Insurance
|
| O: -6.52%
H: 9.88%
C: 4.07%
ketamine pharma patent fibromyalgia implant
Nuvectis Pharma to Present at the 36th Annual Roth Conference
Published: 2024-03-15 (Crawled : 12:00) - globenewswire.com
NVCT | $6.85 1.93% 1.9% 44K
|
|
| O: -0.55%
H: 24.18%
C: 20.88%
pharma conference
NewAmsterdam Pharma Doses First Patient in Phase 3 TANDEM Clinical Trial Evaluating Fixed-Dose Combination of Obicetrapib and Ezetimibe in Patients with HeFH and/or ASCVD
Published: 2024-03-12 (Crawled : 12:00) - globenewswire.com
NAMS | $19.98 2.78% 2.7% 140K
|
n/a
|
| O: -0.14%
H: 14.78%
C: 12.05%
first pharma trial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.